Research questions new Medtronic stent

The Endeavor stent, which Medtronic hopes can hold on to a respectable chunk of the $4 billion worldwide stent market, leads to more complications than rival devices and doesn’t reduce the need for future treatment, according to research presented at a conference yesterday. But the researchers cautioned that the study patients have only been followed for nine months so far, and Endeavor may have been placed into patients who were sicker to start with. Report

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.